Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBITDA: 2009-2024

Historic EBITDA for Innoviva (INVA) over the last 16 years, with Dec 2024 value amounting to $7.8 million.

  • Innoviva's EBITDA fell 20.03% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 20.36%. This contributed to the annual value of $7.8 million for FY2024, which is 80.74% down from last year.
  • As of FY2024, Innoviva's EBITDA stood at $7.8 million, which was up 120.39% from -$38.5 million recorded in FY2024.
  • Over the past 5 years, Innoviva's EBITDA peaked at $93.5 million during FY2021, and registered a low of -$52.3 million during FY2021.
  • For the 3-year period, Innoviva's EBITDA averaged around -$876,667, with its median value being -$12.4 million (2022).
  • Per our database at Business Quant, Innoviva's EBITDA surged by 37.57% in 2022 and then tumbled by 80.74% in 2024.
  • Yearly analysis of 5 years shows Innoviva's EBITDA stood at $74.4 million in 2020, then reached -$52.3 million in 2021, then increased by 25.69% to $93.5 million in 2021, then soared by 37.57% to -$32.7 million in 2022, then slumped by 36.98% to $58.9 million in 2022, then dropped by 27.47% to -$41.6 million in 2023, then plummeted by 30.85% to $40.7 million in 2023, then grew by 7.60% to -$38.5 million in 2024, then slumped by 80.74% to $7.8 million in 2024.